Skip to main content
TipRanks
Go Ultimate75% OFF

Kyverna Therapeutics, Inc. (KYTX) Balance Sheet

1,057 Followers

Kyverna Therapeutics, Inc. Balance Sheet

Kyverna Therapeutics, Inc.'s total assets for Q3 2026 were $189.44M, a decrease of 13.82% from the previous quarter. KYTX total liabilities were $56.28M for the fiscal quarter, a 3.70% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 293.83M$ 304.64M$ 75.19M$ 66.92M$ 85.49M
$ 61.55M$ 38.06M$ 26.02M$ 140.92M$ 131.74M
$ 232.28M$ 266.59M$ 49.18M$ -74.00M$ -46.25M

Currency in USD

Kyverna Therapeutics, Inc. Liabilities to Assets

0120M240M360M0 %80 %160 %240 %LiabilitiesLiabilities to Assets20212022202320242025AssetsLiabilitiesLiabilities to Assets